Survival of transplanted human neural stem cell line (ReNcell VM) into the rat brain with and without immunosuppression

Annals of Anatomy

Volumn 194, Issue 5, 2012, Pages 429-435

  Hovakimyan, M ^a   Muller J ^a   Wree, A ^a   Ortinau, S ^a   Rolfs, A ^a   Schmitt, O ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cell replacement; Immunosuppression; Neural progenitor cells; Ventral mesencephalon

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN TRANSPLANTATION; CELL COUNT; CELL FATE; CELL IMMORTALIZATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG MECHANISM; FETUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MACROGLIA; MALE; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; XENOGRAFT;

ANIMALS; ANTIGENS, NUCLEAR; BLOTTING, WESTERN; BRAIN; CELL COUNT; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTERMEDIATE FILAMENT PROTEINS; NEOSTRIATUM; NERVE TISSUE PROTEINS; NESTIN; NEURAL STEM CELLS; PROTEOME; RATS; STEM CELL TRANSPLANTATION;

RATTUS;

EID: 84865755013     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2012.05.003     Document Type: Article

References (54)

1. Akhlaghi F., Trull A.K. Distribution of cyclosporin in organ transplant recipients. Clin. Pharmacokinet. 2002, 41:615-637.
2. Barker C.F., Billingham R.E. Immunologically privileged sites. Adv. Immunol. 1977, 25:1-54.
3. Bartynski W.S., Zeigler Z., Spearman M.P., Lin L., Shadduck R.K., Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am. J. Neuroradiol. 2001, 22:1901-1914.
4. Ben-Hur T. Immunomodulation by neural stem cells. J. Neurol. Sci. 2008, 265:102-104.
5. Biernacki K., Prat A., Blain M., Antel J.P. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J. Neuropathol. Exp. Neurol. 2001, 60:1127-1136.
6. Blandini F., Cova L., Armentero M.T., Zennaro E., Levandis G., Bossolasco P., Calzarossa C., Mellone M., Giuseppe B., Deliliers G.L., Polli E., Nappi G., Silani V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 2010, 19:203-217.
7. Brevig T., Kristensen T., Zimmer J. Induction of human T-cell proliferation by porcine fetal brain cells: role of astrocytes and macrophages/microglia. Transplant. Proc. 2000, 32:961-962.
8. Borlongan C.V., Freeman T.B., Scorcia T.A., Sherman K.A., Olanow W.C., Cahill D.W., Sanberg P.R. Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats. Cell Transplant. 1995, 4:65-73.
9. Borlongan C.V., Emerich D.F., Hoffer B.J., Bartus R.T. Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity. Brain Res. 2002, 29:211-220.
10. Chiba S., Lee Y.M., Zhou W., Freed C.R. Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 2008, 26:2810-2820.
11. Courtois E.T., Castillo C.G., Seiz E.G., Ramos M., Bueno C., Liste I., Martínez-Serrano A. In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL. J. Biol. Chem. 2010, 285:9881-9897.
12. Dawson T.M., Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 31:819-822.
13. Desai B.S., Monahan A.J., Carvey P.M., Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant. 2007, 16:285-299.
14. Donato R., Miljan E.A., Hines S.J., Aouabdi S., Pollock K., Patel S., Edwards F.A., Sinden J.D. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 2007, 8:36.
15. Dunnett S.B., Kendall A.L., Watts C., Torres E.M. Neuronal cell transplantation for Parkinson's and Huntington's diseases. Br. Med. Bull. 1997, 53:757-776.
16. Dunnett S.B., Björklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 1999, 399:A32-A39.
17. Ebert A.D., Beres A.J., Barber A.E., Svendsen C.N. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp. Neurol. 2008, 209:213-223.
18. Fahn S., Oakes D., Shoulson I., Kieburtz K., Rudolph A., Lang A., Olanow C.W., Tanne r.C., Marek K. Levodopa and the progression of Parkinson's disease. N. Engl. J. Med. 2004, 351:2498-2508. Parkinson Study Group.
19. Flores J., Cepeda I.L., Cornfeldt M.L., O'Kusky J.R., Doudet D.J. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease. J. Neuropathol. Exp. Neurol. 2007, 66:585-596.
20. Friberg H., Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 2002, 84:241-250.
21. Galea I., Bernardes-Silva M., Forse P.A., van Rooijen N., Liblau R.S., Perry V.H. An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J. Exp. Med. 2007, 2023-2030.
22. García J., Carlsson T., Döbrössy M., Nikkhah G., Winkler C. Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and l-DOPA-induced dyskinesia. Neurobiol. Dis. 2011, 43:576-587.
23. Griffin D.E., Hess J.L., Moench T.R. Immune responses in the central nervous system. Toxicol. Pathol. 1987, 15:294-302.
24. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991, 28:254-260.
25. Hoffrogge R., Mikkat S., Scharf C., Beyer S., Christoph H., Pahnke J., Mix E., Berth M., Uhrmacher A., Zubrzycki I.Z., Miljan E., Völker U., Rolfs A. 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 2006, 6:1833-1847.
26. Hori J., Ng T.F., Shatos M., Klassen H., Streilein J.W., Young M.J. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003, 21:405-416.
27. Hovakimyan M., Haas S.J., Schmitt O., Gerber B., Wree A., Andressen C. Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour. J. Anat. 2006, 209:721-732.
28. Hovakimyan M., Haas S.J.P., Schmitt O., Gerber B., Wree A., Andressen C. Mesencephalic human neural progenitor cells transplanted into the adult hemiparkinsonian rat striatum lack dopaminergic differentiation but improve motor behaviour. Cells Tissues Organs 2008, 188:373-383.
29. Ibarra A., Diaz-Ruiz A. Protective effect of cyclosporin-A in spinal cord injury: an overview. Curr. Med. Chem. 2006, 13:2703-2710.
30. Jungnickel J., Kalve I., Reimers L., Nobre A., Wesemann M., Ratzka A., Halfer N., Lindemann C., Schwabe K., Töllner K., Gernert M., Grothe C. Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats. Behav. Brain Res. 2011, 216:129-135.
31. Kaminska B., Gaweda-Walerych K., Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J. Cell. Mol. Med. 2004, 8:45-58.
32. Keep M., Elmér E., Fong K.S., Csiszar K. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res. 2001, 894:327-331.
33. Laguna Goya R., Busch R., Mathur R., Coles A.J., Barker R.A. Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferation. Neurobiol. Dis. 2011, 41:407-414.
34. Lange C., Mix E., Frahm J., Glass A., Müller J., Schmitt O., Schmöle A.C., Klemm K., Ortinau S., Hübner R., Frech M.J., Wree A., Rolfs A. Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells. Neurosci. Lett. 2011, 488:36-40.
35. Larsson L.C., Widner H. Neural tissue xenografting. Scand. J. Immunol. 2000, 52:249-256.
36. Le Belle J.E., Caldwell M.A., Svendsen C.N. Improving the survival of human CNS precursor-derived neurons after transplantation. J. Neurosci. Res. 2004, 76:174-183.
37. Liu Y.J., Guo D.W., Tian L., Shang D.S., Zhao W.D., Li B., Fang W.G., Zhu L., Chen Y.H. Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent. Neurobiol. Aging 2010, 31:175-188.
38. Lindvall O., Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004, 1:382-393.
39. Lindvall O., Kokaia Z., Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 2004, 10:42-50.
40. Lynch M.A., Mills K.H. Immunology meets neuroscience-opportunities for immune intervention in neurodegenerative diseases. Brain. Behav. Immun. 2011, 26:1-10.
41. Mendez I., Viñuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J.Q., Isacson O. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 2008, 14:507-509.
42. Michel-Monigadon D., Bonnamain V., Nerrière-Daguin V., Dugast A.S., Lévèque X., Plat M., Venturi E., Brachet P., Anegon I., Vanhove B., Neveu I., Naveilhan P. Trophic and immunoregulatory properties of neural precursor cells: benefit for intracerebral transplantation. Exp. Neurol. 2011, 230:35-47.
43. Miljan E.A., Hines S.J., Pande P., Corteling R.L., Hicks C., Zbarsky V., Umachandran M., Sowinski P., Richardson S., Tang E., Wieruszew M., Patel S., Stroemer P., Sinden J.D. Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease. Stem Cells Dev. 2009, 18:307-319.
44. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Björklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1994, 63:57-72.
45. Piccini P., Lindvall O., Björklund A., Brundin P., Hagell P., Ceravolo R., Oertel W., Quinn N., Samuel M., Rehncrona S., Widner H., Brooks D.J. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann. Neurol. 2000, 48:689-690.
46. Ratzka A., Kalve I., Ozer M., Nobre A., Wesemann M., Jungnickel J., Köster-Patzlaff C., Baron O., Grothe C. The co-layer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease. Cell Transplant. 2011, [Sep 16; Epub ahead of print].
47. Roybon L., Christophersen N.S., Brundin P., Li J.Y. Stem cell therapy for Parkinson's disease: where do we stand?. Cell Tissue Res. 2004, 318:261-273.
48. Schindowski K., Eckert A., Peters J., Gorriz C., Schramm U., Weinandi T., Maurer K., Frölich L., Müller W.E. Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy. Neuromol. Med. 2007, 9:340-354.
49. Sinigaglia-Coimbra R., Cavalheiro E.A., Coimbra C. Protective effect of systemic treatment with cyclosporine A after global ischemia in rats. J. Neurol. Sci. 2002, 203-204:273-276.
50. Tedroff J.M. Functional consequences of dopaminergic degeneration in Parkinson's disease. Adv. Neurol. 1999, 80:67-70.
51. Wang X., Lu Y., Zhang H., Wang K., He Q., Wang Y., Liu X., Li L., Wang X. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int. J. Dev. Neurosci. 2004, 22:175-183.
52. Wennberg L., Czech K.A., Larsson L.C., Mirza B., Bennet W., Song Z., Widner H. Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats. Transplantation 2001, 71:1797-1806.
53. Wennersten A., Holmin S., Al Nimer F., Meijer X., Wahlberg L.U., Mathiesen T. Sustained survival of xenografted human neural stem/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. Exp. Neurol. 2006, 199:339-347.
54. Winkler C., Kirik D., Björklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 2005, 28:86-92.